Temperature dependent polymorphism of pyrazinamide: An in situ Raman and DFT study

Spectrochim Acta A Mol Biomol Spectrosc. 2018 Feb 5:190:177-180. doi: 10.1016/j.saa.2017.09.016. Epub 2017 Sep 13.

Abstract

The α and γ polymorphs of drug pyrazinamide have been detected with the help of temperature dependent Raman spectroscopic technique. Pyrazinamide is a very useful drug used for the treatment of tuberculosis (TB) and plays a significant role in destroying the dormant tubercle bacilli which are not destroyed by other common TB drugs. Temperature dependent Raman spectra suggest polymorphic phase change from α→γ form of pyrazinamide between 145 and 146°C. In situ Raman spectra of pyrazinamide between 145 and 146°C show the conversion of α→γ form by the shift in CO stretching vibration accompanied by several other changes. The phase change is characterized by the breaking of two linear NH⋯O type hydrogen bonds associated with CO stretching vibration in α dimer and formation of one linear NH⋯N type hydrogen bond along with a weak intramolecular CH⋯O type hydrogen bond in the γ dimer.

Keywords: DFT; Hydrogen bonding; Pyrazinamide; Raman spectroscopy; Tuberculosis.

MeSH terms

  • Dimerization
  • Models, Molecular*
  • Molecular Conformation
  • Pyrazinamide / chemistry*
  • Quantum Theory*
  • Spectrum Analysis, Raman*
  • Temperature*
  • Vibration
  • X-Ray Diffraction

Substances

  • Pyrazinamide